These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25575721)

  • 1. Study supports link between injectable hormonal contraceptive and HIV risk.
    Wise J
    BMJ; 2015 Jan; 350():h112. PubMed ID: 25575721
    [No Abstract]   [Full Text] [Related]  

  • 2. End of the debate on hormonal contraception and HIV risk?
    Lancet Infect Dis; 2015 Feb; 15(2):131. PubMed ID: 25749056
    [No Abstract]   [Full Text] [Related]  

  • 3. Broadening the debate over HIV and hormonal contraception.
    Colvin CJ; Harrison A
    Lancet Infect Dis; 2015 Feb; 15(2):135-6. PubMed ID: 25578824
    [No Abstract]   [Full Text] [Related]  

  • 4. Research on hormonal contraception and HIV.
    Redd AD
    Lancet; 2014 Jan; 383(9914):305. PubMed ID: 24461118
    [No Abstract]   [Full Text] [Related]  

  • 5. Research on hormonal contraception and HIV.
    Gollub EL; Stein Z
    Lancet; 2014 Jan; 383(9914):304-5. PubMed ID: 24461117
    [No Abstract]   [Full Text] [Related]  

  • 6. Research on hormonal contraception and HIV.
    Cates W;
    Lancet; 2014 Jan; 383(9914):303-4. PubMed ID: 24461116
    [No Abstract]   [Full Text] [Related]  

  • 7. Research on hormonal contraception and HIV - Authors' reply.
    Ralph L; McCoy S; Hallett T; Padian N
    Lancet; 2014 Jan; 383(9914):305-6. PubMed ID: 24461119
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.
    Hapgood JP
    Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions.
    Chen PL; Cole SR; Morrison CS
    Epidemiology; 2011 Nov; 22(6):877-8. PubMed ID: 21968782
    [No Abstract]   [Full Text] [Related]  

  • 10. Next steps for research on hormonal contraception and HIV.
    Ralph LJ; McCoy SI; Hallett T; Padian N
    Lancet; 2013 Nov; 382(9903):1467-9. PubMed ID: 23810224
    [No Abstract]   [Full Text] [Related]  

  • 11. Two recent studies find Depo-Provera use increases HIV risk.
    Harper KN
    AIDS; 2015 Jun; 29(9):N1. PubMed ID: 25870992
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ; McCoy SI; Shiu K; Padian NS
    Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "hormonal contraception and HIV prevalence in four African countries".
    Gisselquist D
    Contraception; 2008 Oct; 78(4):346; author reply 346-7. PubMed ID: 18847587
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition.
    Morrison CS; Richardson BA; Celentano DD; Chipato T; Mmiro F; Mugerwa R; Padian NS; Rugpao S; Salata RA
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S17-8. PubMed ID: 15867602
    [No Abstract]   [Full Text] [Related]  

  • 16. The early work on hormonal contraceptive use and HIV acquisition.
    Martin HL; Richardson BA; Mandaliya K; Achola JO; Overbaugh J; Kreiss JK
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S12-4. PubMed ID: 15867600
    [No Abstract]   [Full Text] [Related]  

  • 17. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.
    van Hylckama Vlieg A; Helmerhorst FM; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2297-300. PubMed ID: 20798377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions.
    Jones HE
    Contraception; 2014 Oct; 90(4):357-9. PubMed ID: 24993486
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response.
    Nene Z; Hofmeyr GJ; Patel M; Panday M; Rees H; Makua M; Pillay Y
    S Afr Med J; 2018 Jul; 108(8):629-631. PubMed ID: 30182875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.